| Pharmaceutical active ingredients: |
| GuaifenesinPhenylpropanolamine Hydrochloride |
| Available forms, composition and doses of Silaminic Expectorant: |
| N / A |
| Silaminic Expectorant medical category: |
| Human:Cough and cold preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA51 - Phenylpropanolamine, combinationsR05CA03 - Guaifenesin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Silarx Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Poly-Histine Expectorant | Guaifenesin; Phenylpropanolamine Hydrochloride | Sanofi-Aventis |
| Profen | Guaifenesin; Phenylpropanolamine Hydrochloride | IVAX |
| Profen Forte | Guaifenesin; Phenylpropanolamine Hydrochloride | IVAX |
| Rephenyl | Guaifenesin; Phenylpropanolamine Hydrochloride | Reese Pharmaceutical |
| Rymed-TR | Guaifenesin; Phenylpropanolamine Hydrochloride | Edwards Pharmaceuticals |
| Sildicon-E | Guaifenesin; Phenylpropanolamine Hydrochloride | Silarx Pharmaceuticals |
| SINUvent | Guaifenesin; Phenylpropanolamine Hydrochloride | WE Pharmaceuticals |
| Snaplets-EX | Guaifenesin; Phenylpropanolamine Hydrochloride | IVAX |
| Stamoist LA | Guaifenesin; Phenylpropanolamine Hydrochloride | Huckaby Pharmacal |
| Tri-Clear Expectorant | Guaifenesin; Phenylpropanolamine Hydrochloride | Warner Chilcott |